Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 11,799 | 18 | 1,128 | 8,158 | 17,530 |
| Cost of Goods | 1,009 | N/A | 1,803 | 600 | 28 |
| Gross Profit | 10,790 | 18 | -675 | 7,558 | 17,502 |
| Operating Expenses | 137,538 | 109,496 | 77,308 | 28,108 | 16,732 |
| Operating Income | -126,739 | -109,478 | -77,180 | -19,950 | 798 |
| Interest Expense | 0 | 0 | 0 | 31 | 2,739 |
| Other Income | 1,629 | 4,332 | 1,648 | 0 | 0 |
| Pre-tax Income | -125,110 | -105,146 | -75,532 | -19,981 | -1,941 |
| Income Tax | 3,374 | N/A | 125 | 19 | N/A |
| Net Income Continuous | -128,484 | -105,146 | -75,657 | -20,000 | -1,941 |
| Net Income | $-128,484 | $-105,146 | $-75,657 | $-20,000 | $-1,941 |
| EPS Basic Total Ops | -5.90 | -5.12 | -4.80 | -2.14 | -1.91 |
| EPS Basic Continuous Ops | -5.90 | -5.12 | -4.80 | -2.06 | -0.84 |
| EPS Diluted Total Ops | -5.90 | -5.12 | -4.80 | -2.14 | -1.91 |
| EPS Diluted Continuous Ops | -5.90 | -5.12 | -4.80 | -2.06 | -0.84 |
| EPS Diluted Before Non-Recurring Items | -5.90 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-125,884 | $-109,754 | $-76,763 | $-19,743 | $1,011 |